These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 3545883

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Ambroxol decreases bronchial hyperreactivity.
    Melillo G, Cocco G.
    Eur J Respir Dis; 1986 Nov; 69(5):316-20. PubMed ID: 3539631
    [Abstract] [Full Text] [Related]

  • 24. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM, Rajasekaran S, Paramesh P, Krishnarajasekar OR, Vasudevan S, Nalini K, Lakshmisubramanian S, Deivanayagam CN.
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [Abstract] [Full Text] [Related]

  • 25. [Comparative evaluation of the effectiveness of lasolvan and mucodine in chronic nonspecific lung diseases].
    Solopov VN, Kolganova NA.
    Sov Med; 1988 Jan; (5):69-72. PubMed ID: 3062806
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Long-term treatment of chronic bronchitis with ambroxol].
    Schöpp W.
    ZFA (Stuttgart); 1981 Sep 20; 57(26):1778-86. PubMed ID: 7303838
    [No Abstract] [Full Text] [Related]

  • 29. [The effect of inhaled ambroxol treatment on clinical symptoms and chosen parameters of ventilation in patients with exacerbation of chronic obstructive pulmonary disease patients].
    Jahnz-Rózyk K, Kucharczyk A, Chciałowski A, Płusa T.
    Pol Merkur Lekarski; 2001 Sep 20; 11(63):239-43. PubMed ID: 11761819
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Therapeutic activity of ambroxol theophyllinacetate in chronic obstructive pulmonary diseases.
    Primbs K.
    Clin Ther; 1985 Sep 20; 7(6):733-6. PubMed ID: 4075364
    [Abstract] [Full Text] [Related]

  • 32. Normalization of bronchial exocrine pathology after endobronchial treatment with ambroxol.
    Aliperta A, Bellissimo U, Turco D, Antinolfi G.
    Int J Tissue React; 1986 Sep 20; 8(2):167-74. PubMed ID: 2939036
    [Abstract] [Full Text] [Related]

  • 33. Influence of ambroxol on lung tissue penetration of amoxicillin.
    Spátola J, Poderoso JJ, Wiemeyer JC, Fernández M, Guerreiro RB, Corazza C.
    Arzneimittelforschung; 1987 Aug 20; 37(8):965-6. PubMed ID: 3675694
    [Abstract] [Full Text] [Related]

  • 34. [Prophylaxis and treatment of bronchopulmonary complications with ambroxol administered by infusion in elderly patients undergoing surgery].
    Bavaro P, Biscari P.
    G Chir; 1989 Oct 20; 10(10):605-9. PubMed ID: 2518303
    [Abstract] [Full Text] [Related]

  • 35. Ambroxol for prophylaxis and treatment of bronchopulmonary complications after chest surgery.
    Romanini BM, Sandri MG, Tosi M, Mezzetti M, Mazzetti A.
    Int J Clin Pharmacol Res; 1986 Oct 20; 6(2):123-7. PubMed ID: 3522443
    [Abstract] [Full Text] [Related]

  • 36. Double-blind crossover trial of bromhexine (Bisolvon) in the treatment of chronic bronchitis.
    Armstrong ML.
    Med J Aust; 1976 Apr 24; 1(17):612,614-5,617. PubMed ID: 778563
    [Abstract] [Full Text] [Related]

  • 37. Ambroxol in the treatment of idiopathic respiratory distress syndrome. An interim report on a controlled double-blind multicenter study versus placebo.
    Marini A, Franzetti M, Gios G, Flauto U, Arosio A, Maccabruni M, Rondini G, Chirico G, Giancola A, Console V.
    Respiration; 1987 Apr 24; 51 Suppl 1():60-7. PubMed ID: 3299568
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
    Marchioni CF, Polu JM, Taytard A, Hanard T, Noseda G, Mancini C.
    Int J Clin Pharmacol Ther; 1995 Nov 24; 33(11):612-8. PubMed ID: 8688986
    [Abstract] [Full Text] [Related]

  • 39. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.
    Boman G, Bäcker U, Larsson S, Melander B, Wåhlander L.
    Eur J Respir Dis; 1983 Aug 24; 64(6):405-15. PubMed ID: 6350033
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.